Home › Recently closed › 2026-18946
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing
Comment period closed: closed 1 day ago (Oct 16, 2026).
Read on FederalRegister.gov · Official PDF · Docket on Regulations.gov · Add to calendar (.ics)
Summary (from the Federal Register abstract)
The Food and Drug Administration (FDA, Agency, or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
- Document type
- Notice
- Federal Register document number
- 2026-18946
- Published
- Sep 16, 2026
- Action
- Notice.
- Docket
- FDA-2026-N-0027
- Comments posted on Regulations.gov (at last check)
- 0
- DATES section (from the document)
- Submit written comments (including recommendations) on the collection of information by October 16, 2026.
- Topics (auto-tagged)
- Vaccines / biologics
Source: Federal Register API, document 2026-18946. Federal Register text is a U.S. government work. Confirm dates in the official document; later documents may extend, reopen or correct them.